fluoxetine has been researched along with corticosterone in 193 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (6.22) | 18.7374 |
1990's | 8 (4.15) | 18.2507 |
2000's | 45 (23.32) | 29.6817 |
2010's | 105 (54.40) | 24.3611 |
2020's | 23 (11.92) | 2.80 |
Authors | Studies |
---|---|
Caron, G; Ermondi, G | 1 |
Ahman, M; Holmén, AG; Wan, H | 1 |
Kong, LY; Li, RJ; Luo, J; Quasie, O; Xu, WJ; Yang, MH | 1 |
Clemens, JA; Fuller, RW; Snoddy, HD | 1 |
Breese, GR; Duncan, GE; Hong, JS; Kuhn, C; Mueller, RA; Paul, IA | 1 |
Gudelsky, GA; Meltzer, HY; Nash, JF | 1 |
Bethea, CL; Richardson, KD; Urban, JH; Van de Kar, LD | 1 |
Bero, LA; Kuhn, CM | 1 |
Fuller, RW; Stark, P; Wong, DT | 1 |
Hauser, K; Häusler, A; Meeker, JB | 1 |
McElroy, JF; Meyer, JS; Miller, JM | 1 |
Fuller, RW; Snoddy, HD | 1 |
Cerrito, F; Preziosi, P; Vacca, M | 1 |
Eisenberg, RM; Knych, ET | 1 |
Grota, LJ | 1 |
Fuller, RW | 1 |
Bianchi, M; Panerai, AE; Sacerdote, P | 1 |
Engleman, E; Fuller, RW; Hemrick-Luecke, SK; Perry, KW | 1 |
Hamon, M; Laaris, N; Lanfumey, L; Le Poul, E | 1 |
Breese, GR; Carson, SW; Duncan, GE; Knapp, DJ | 1 |
Ayestas, MA; Baumann, MH; Rothman, RB | 1 |
Aguerre, S; Berton, O; Chaouloff, F; Durand, M; Mormède, P | 1 |
Anglade, G; Faudon, M; Hery, F; Marcilhac, A; Siaud, P | 1 |
Battaglia, G; Garcia, F; Ma, Q; Raap, DK; Serres, F; Van de Kar, LD; Zhang, Y | 1 |
Branchek, TA; Calligaro, DO; Czachura, JF; Dreshfield-Ahmad, LJ; Evans, DC; Hemrick-Luecke, SK; Kallman, MJ; Kendrick, WT; Leander, JD; Nelson, DL; Overshiner, CD; Rasmussen, K; Wainscott, DB; Wolff, MC; Wong, DT; Xu, YC; Zgombick, JM | 1 |
Fache, M; Faudon, M; Héry, F; Héry, M; Sémont, A; Youssouf, F | 1 |
Avitsur, R; Barak, O; Bette, M; Ovadia, H; Pollak, Y; Weidenfeld, J; Weihe, E; Yirmiya, R | 1 |
Hibberd, C; Noble, J; Seckl, JR; Yau, JL | 1 |
Biggio, G; Dazzi, L; Muggironi, M; Papi, G; Parodo, V; Pisu, MG; Purdy, RH; Sari, R; Serra, M; Spiga, F | 1 |
Blendy, JA; Conti, AC; Cryan, JF; Dalvi, A; Lucki, I | 1 |
Anwyl, R; Rowan, MJ; Shakesby, AC | 1 |
Battaglia, G; DonCarlos, LL; Garcia, F; Muma, NA; Raap, DK; Van de Kar, LD | 1 |
Battaglia, G; D'Souza, DN; Garcia, F; Van De Kar, LD; Zhang, Y | 2 |
Duman, RS; Malberg, JE | 1 |
Kerwin, RW; Kim, RB; Makoff, A; Pariante, CM | 1 |
Huang, WC; Li, YF; Liu, YQ; Luo, ZP | 1 |
Goyal, A; Hallas, BH; Horowitz, AT; Horowitz, JM; Ramdeen, N; Torres, G | 1 |
Duxon, MS; Hagan, JJ; Hendrie, CA; Pickles, AR; Riley, G | 1 |
Battaglia, G; Chen, Z; Frasier, M; Garcia, F; Landry, M; Van De Kar, LD; Zhang, Y | 1 |
Arregi, A; Azpiroz, A; Beitia, G; Brain, PF; Garmendia, L; Vegas, O | 1 |
Herbert, J; Huang, GJ | 1 |
Dwivedi, Y; Pandey, GN; Rizavi, HS | 1 |
Che, W; Matsumoto, K; Min-Wei, W; Murakami, Y; Song, L | 1 |
Chen, H; Dwivedi, Y; Pandey, GN | 1 |
Bradford, DW; Butterfield, MI; Grobin, AC; Khisti, RT; Lieberman, JA; Madison, RD; Marx, CE; Massing, MW; Morrow, AL; Shampine, LJ; Trost, WT | 1 |
Epp, JR; Keith, JR; Spanswick, SC; Sutherland, RJ | 1 |
Banasr, M; Duman, RS; Gourley, SL; Li, XY; Taylor, JR; Valentine, GW | 1 |
Higashi, M; Hitoshi, S; Ikenaka, K; Kato, N; Kumar, A; Maruta, N | 1 |
Duman, RS; Gourley, SL; Kedves, AT; Kiraly, DD; Ploski, JE; Taylor, JR; Wu, FJ | 1 |
Bulygina, VV; Dygalo, NN; Iudina, AM; Shishkina, GT; Tolstikova, TG | 1 |
Dronjak, S; Gavrilovic, L; Spasojevic, N; Varagic, V | 1 |
Lolait, SJ; O'Carroll, AM; Roper, JA; Stewart, LQ; Young, WS | 1 |
Hutson, PH; Murray, F; Smith, DW | 1 |
Adrien, J; Alexandre, C; Léna, C; Popa, D | 1 |
Akil, H; Calvo, N; Cecchi, M; Jama, A; Watson, SJ | 1 |
Brigman, JL; Cameron, HA; Enoch, AJ; Harvey-White, J; Holmes, A; Karlsson, RM; Mathur, P; Norcross, M; Poonam, M | 1 |
Alahmed, S; Herbert, J | 1 |
Hale, MW; Ingram, CD; Lightman, SL; Lowry, CA; Plant, A; Renner, KJ; Shanks, N; Summers, CH; Windle, RJ; Wood, SA | 1 |
Herbert, J; Lazic, SE; Pinnock, SB; Wong, HT; Wong, IH | 1 |
Cheng, G; Kong, LD; Li, YC; Pan, Y; Qiang, LQ; Wang, FM; Zhang, WY | 1 |
Burke, KA; Hale, MW; Lowry, CA; Moore, FL; Renner, KJ | 1 |
Ciccocioppo, R; Cifani, C; Di Francesco, C; Massi, M; Melotto, S; Righetti, C; Tessari, M; Zanoncelli, A | 1 |
Lledo, PM | 1 |
Antonijevic, IA; Artymyshyn, RP; Craig, DA; David, DJ; Drew, M; Gardier, AM; Gerald, C; Guiard, BP; Guilloux, JP; Hen, R; Leonardo, ED; Marsteller, D; Mendez, I; Rainer, Q; Samuels, BA; Wang, JW | 1 |
Hodes, GE; Santollo, J; Shors, TJ; Van Kooy, J; Yang, L | 1 |
Brown, RE; Martin, AL | 1 |
Alleva, E; Branchi, I; Cirulli, F; D'Andrea, I; Lipp, HP | 1 |
Breese, G; Fredericks, K; Knapp, D; McMichael, J; Overstreet, DH | 1 |
Calandra, T; Castro, JE; Conboy, L; Lashuel, HA; Sakouhi-Ouertatani, H; Sandi, C; Varea, E | 1 |
Arteaga-Silva, M; Bonilla-Jaime, H; Hernández-González, M; Retana-Márquez, S; Vázquez-Palacios, G | 1 |
Andrews, AM; Earnheart, JC; Lal, R; Luellen, BA; Luscher, B; Shen, Q | 1 |
Clesse, D; Darcq, E; Goeldner, C; Halter, T; Kieffer, BL; Lutz, PE; Ouagazzal, AM | 1 |
Dong, J; Du, J; Le, J; Liu, B; Wu, J; Xu, C; Xu, Y | 1 |
Birkett, MA; Kessler, EJ; Meyer, JS; Ritchie, S; Rowlett, JK; Shinday, NM | 1 |
David, DJ; Enhamre, E; Gabriel, C; Gardier, AM; Guilloux, JP; Hen, R; Mocaër, E; Rainer, Q; Xia, L | 1 |
Belzung, C; Griebel, G; Hen, R; Ibarguen-Vargas, Y; Laugeray, A; Leonardo, ED; Palme, R; Rainer, Q; Surget, A; Tanti, A; Touma, C | 1 |
Acharya, AP; Barish, PA; Boykin, E; Chen, L; Govindarajan, SS; Li, S; O'Donnell, JM; Ogle, WO; Pan, J; Pan, X; Vernon, MM; Xu, Y; Yu, J; Zhang, Y | 1 |
Bondarenko, E; Carnevali, L; Day, TA; Head, GA; Lukoshkova, EV; Nalivaiko, E; Sgoifo, A; Walker, FR | 1 |
Araujo, IG; Côrtes, WS; Marassi, MP; Mecawi, AS; Olivares, EL; Pestana, FM; Reis, LC; Rocha, FF; Rodrigues, NC; Silva-Almeida, C; Sonoda-Côrtes, R | 1 |
Fitzgerald, PJ; Hefner, KR; Holmes, A; Ihne, JL | 1 |
Graham, DL; Morford, LR; Skelton, MR; Vorhees, CV; Williams, MT | 1 |
David, DJ; Gardier, AM; Guiard, BP; Nguyen, HT; Quesseveur, G; Rainer, Q | 1 |
Che, CT; Huang, Z; Ip, SP; Mao, QQ; Xian, YF | 1 |
Budni, J; Colla, A; de Freitas, AE; de Oliveira Balen, G; dos Santos, DB; Farina, M; Moretti, M; Severo Rodrigues, AL | 1 |
Charlier, TD; Crispin, HT; Fillet, M; Houbart, V; Pawluski, JL; Steinbusch, HW; van den Hove, DL | 1 |
Lin, SY; Lin, YL; Wang, S | 1 |
Bravo, JA; Camp, MC; Ciocchi, S; Cryan, JF; Debrouse, LM; Gaburro, S; Graybeal, C; Holmes, A; Ihne, JL; Lederle, L; Lüthi, A; Macpherson, KP; O'Connor, RM; Singewald, N; Wellman, CL | 1 |
Chhillar, R; Dhingra, D | 1 |
Coudoré, F; David, DJ; Gardier, AM; Guiard, BP; Hache, G; Le Dantec, Y; Orvoën, S | 1 |
Cortés, R; García del Caño, G; Mengod, G; Montaña, M; Saenz del Burgo, L; Sallés, J | 1 |
Breuillaud, L; Cardinaux, JR; Halfon, O; Magistretti, PJ; Mérinat, C; Meylan, EM; Rossetti, C | 1 |
Alcantara, LF; Bolaños-Guzmán, CA; Feng, J; Iñiguez, SD; Kennedy, PJ; Laplant, Q; Nestler, EJ; Shen, L; Vialou, VF; Warren, BL; Wright, KN | 1 |
Balen, GO; Bettio, LE; Brocardo, PS; Capra, JC; Colla, A; Cunha, MP; Grando, J; Machado, DG; Neis, VB; Rodrigues, AL | 1 |
Jahng, JW; Kang, DW; Kim, BT; Kim, JY; Lee, JH; Ryu, V; Yoo, SB | 1 |
Altimus, CM; Hattar, S; Kirkwood, A; Lee, HK; LeGates, TA; Wang, H; Weber, ET; Yang, S; Zhao, H | 1 |
Gao, Y; Li, Z; Liu, H; Wu, Y; Xu, Z; Zhang, C; Zhang, S | 1 |
Amani, M; Babri, S; Bakhtiari, A; Doosti, MH; Majidi-Zolbanin, N; Salari, AA; Zare, P | 1 |
Chuang, JC; Gillman, AG; Kumar, J; Kuperman, A; Lutter, M; McClung, CA; Mukherjee, S; Na, ES; Zigman, JM | 1 |
Adzic, M; Djordjevic, J; Mitic, M; Radojcic, MB; Simic, I | 1 |
Gądek-Michalska, A; Kabziński, M; Rachwalska, P; Rogóż, Z; Sadaj, W | 1 |
Mendes-Gomes, J; Nunes-de-Souza, RL; Rico, JL; Rodgers, RJ; Sorregotti, T | 1 |
Alleva, E; Branchi, I; Capoccia, S; Cirulli, F; D'Andrea, I; Poggini, S; Santarelli, S | 1 |
Cai, L; Li, R; Wu, QQ; Wu, TN | 1 |
Asada, M; Ikeda, Y; Inagaki, H; Kawada, T; Kobayashi, K; Suzuki, H | 1 |
Chen, Y; Cheng, Y; Gong, M; Liang, B; Wang, G; Xu, J; Yuan, X; Zhang, C; Zhang, M | 1 |
Darcet, F; David, DJ; Gardier, AM; Hen, R; Kerdine-Römer, S; Mendez-David, I; Wu, MV | 1 |
Fan, Y; Li, M; Li, S; Ma, Y; Ren, Y; Sawmiller, D; Tan, J; Wang, C | 1 |
Hen, R; Wu, MV | 1 |
Boyle, LM; Duman, RS; Kronman, HG; Monsey, MS; Nguyen, CP; Ota, KT; Schafe, GE; Taylor, JR; Zhang, ML | 1 |
Arbabi, L; Baharuldin, MT; Fakurazi, S; Moklas, MA; Muhammad, SI | 1 |
Bhankher, A; Dhingra, D | 1 |
Chen, L; Guan, XT; Shao, F; Wang, W; Xie, X | 1 |
Chen, L; Dai, J; Huang, Y; Wang, Z; Zhang, H; Zhao, Y | 1 |
Her, S; Hong, KS; Kim, YH; Kwon, SH; Lee, MS; Lyons, DM; Morita, K; Park, OK; Park, WS; Patel, PD; Rhim, H; Schatzberg, AF; Shim, I; Wong, DL | 1 |
Arnold, KE; Bean, TG; Boxall, AB; Herborn, KA; Lane, J; Pietravalle, S | 1 |
Gupta, D; Kanade, P; Kurhe, Y; Prabhakar, V; Radhakrishnan, M; Thangaraj, D | 1 |
García-García, L; Gomez, F; Venero, C; Viveros, MP | 1 |
Boeira, SP; da Silva Antunes, M; de Gomes, MG; Del Fabbro, L; Donato, F; Filho, CB; Giacomeli, R; Goes, AT; Jesse, CR; Prigol, M; Souza, LC | 1 |
Jin, P; Quan, ZS; Yu, HL; Zhang, F | 1 |
Ali, ZE; Damiens, MH; David, DJ; Gardier, AM; Kerdine-Römer, S; Mendez-David, I; Pallardy, M; Tritschler, L | 1 |
Almeida, J; Crestani, CC; Duarte, JO; Oliveira, LA | 1 |
Alvarado, G; Artigas, F; Bortolozzi, A; Campa, L; Caso, JR; Ferrés-Coy, A; Galofré, M; Leza, JC; Montefeltro, A; Paz, V; Pazos, Á; Pilar-Cuéllar, F; Ruiz-Bronchal, E; Valdizán, EM; Vidal, R | 1 |
Bose, R; Ceccatelli, S; Conti, M; DuPont, C; Onishchenko, N; Raciti, M; Spulber, S | 1 |
Frey, BN; Nashed, MG; Seidlitz, EP; Singh, G | 1 |
Chen, L; Huang, Y; Ou Yang, L; Wang, Z; Zhao, Y; Zhu, K | 1 |
Chow, C; Galea, LA; Gobinath, AR; Lieblich, SE; Workman, JL | 1 |
Deng, XY; Fu, Q; Li, HY; Ma, SP; Ma, ZQ; Qu, R; Xue, JS | 1 |
Barha, CK; Chow, C; Epp, JR; Galea, LA; Hamson, DK; Lieblich, SE; Rutishauser, U; Wainwright, SR | 1 |
Ji, L; Li, H; Liu, W; Wang, Y | 1 |
Colla, AR; Cunha, MP; Lieberknecht, V; Oliveira, Á; Pazini, FL; Rodrigues, AL; Rosa, JM | 1 |
Gao, Q; Gao, Y; Liang, Y; Ma, Y; Shi, H; Wang, X; Wu, S; Xi, Y; Zhao, P | 1 |
Chu, K; Jeon, D; Jeong, B; Jeong, Y; Jung, KH; Khalid, A; Kim, S; Lee, SK; Lee, ST | 1 |
de Chaumont, F; Denizet, M; Gabellec, MM; Guilloux, JP; Lazarini, F; Lledo, PM; Olivo-Marin, JC; Siopi, E | 1 |
Brummelte, S; Chow, C; Galea, LAM; Gobinath, AR; Kitay, NF; Workman, JL | 1 |
Darcet, F; David, DJ; Gardier, AM; Guilloux, JP | 1 |
Chaiton, JA; Galea, LAM; Lieblich, SE; Mahmoud, R; Wainwright, SR | 1 |
Poleszak, E; Rechberger, T; Serefko, A; Wróbel, A | 1 |
Fatehi-Gharehlar, L; Homberg, JR; Motayagheni, N; Salari, AA | 1 |
Avitsur, R; Chlebowski, N; Goren, N; Grinshpahet, R; Kirshenboim, O; Weinstein, I | 1 |
Belzung, C; Heinzmann, JM; Knapman, A; McIlwrick, S; Surget, A; Touma, C; Van Nieuwenhuijzen, PS; Westphal, WP | 1 |
Cheng, Y; Li, Y; Liu, Y; Niu, B; Wang, H; Wang, X; Xu, J; You, T; Zeng, B; Zhou, Z | 1 |
Ayuob, NN | 1 |
Azevedo, D; Brocardo, PS; Colla, A; Cunha, MP; de Oliveira, J; Gil-Mohapel, J; Pazini, FL; Ramos-Hryb, AB; Rodrigues, ALS; Rosa, JM | 1 |
Chen, JJ; Fang, XY; Li, YC; Liu, YM; Pei, YY; Shen, JD | 1 |
García-García, L; Gomez, F | 1 |
Jiang, ZE; Li, MM; Quan, ZS; Song, LY; Yu, HL | 1 |
Avitsur, R | 1 |
Chow, C; Galea, LAM; Gobinath, AR; Lieblich, SE; Workman, JL | 1 |
Chen, L; Dai, JG; Huang, YF; Lin, ZX; Wang, X; Zhao, YN | 1 |
Aswar, MK; Kulkarni, YP; Patel, BM; Patil, RR; Thakare, VN | 1 |
Omar, NN; Tash, RF | 1 |
Azevedo, DP; Brocardo, PS; Fraga, DB; Gil-Mohapel, J; Melleu, FF; Neis, VB; Olescowicz, G; Rodrigues, ALS; Rosa, PB | 1 |
Bögi, E; Charlier, TD; Fillet, M; Gemmel, M; Hammond, GL; Harmeyer, D; Hill, LA; Pawluski, JL | 1 |
Aswar, MK; Dhakane, VD; Oswal, RJ; Patel, BM; Patil, RR; Thakare, VN | 1 |
Chen, F; Chen, L; Gu, L; Lin, Z; Ouyang, L; Zhang, Q; Zhao, Y | 1 |
Abd El Wahab, MG; Ali, SS; Ayuob, NN | 1 |
Js, IC; Kv, A; Lahkar, M; Madhana, RM; Naidu, VGM; Sinha, S | 1 |
Belovicová, K; Bogi, E; Dubovicky, M; Garafová, A; Jezova, D; Koprdova, R; Mach, M; Ujhazy, E; Zilava, L | 1 |
Barr, AM; Chow, C; Galea, LAM; Gobinath, AR; Lieblich, SE; Wong, S | 1 |
Camargo, A; da Silva, EB; Dalmagro, AP; Rikel, L; Simão da Silva, KAB; Zeni, ALB | 1 |
Bettio, LB; Fraga, DB; Freitas, AE; Gonçalves, FM; Heinrich, IA; Leal, RB; Lopes, MW; Moretti, M; Neis, VB; Olescowicz, G; Rodrigues, ALS; Rosa, PB | 1 |
Cheng, YF; Hsu, CC; Liao, CL; Tsai, YC; Wang, S; Wei, CL; Wu, CC; Yen, JT | 1 |
Camargo, A; Dalmagro, AP; Zeni, ALB | 1 |
Barbosa, MA; Ceravolo, GS; Gerardin, DCC; Moreira, EG; Pelosi, GG; Veríssimo, LF | 1 |
Ji, M; Li, S; Mao, M; Qiu, L; Xia, J; Yang, J; Zong, M | 1 |
Cosentino, L; De Filippis, B; Flor, H; Fuso, A; Lucarelli, M; Medici, V; Vigli, D | 1 |
Bian, Y; Ding, J; Hu, G; Lu, M; Shu, X; Shu, Z; Sun, X; Sun, Y; Zhou, Y | 1 |
Diez-Alarcia, R; Horrillo, I; Meana, JJ; Ortega, JE; Urigüen, L | 1 |
Ashamalla, SA; Bokka, L; Garino, A; Gergues, MM; Samuels, BA; Yohn, CN | 1 |
Goudarzi, M; Nahavandi, A; Zavvari, F | 1 |
Camargo, A; Dalmagro, AP; Garcia, SAM; Pedron, NB; Zeni, ALB | 1 |
Brocardo, PS; de Paula Nascimento-Castro, C; Gil-Mohapel, J; Olescowicz, G; Rodrigues, ALS; Sampaio, TB | 1 |
B Neis, V; B Zeni, AL; Camargo, A; Dalmagro, AP; F Rosado, A; P Kaster, M; Platt, N; S Rodrigues, AL | 1 |
Bais, AK; K V, A; Kumar, P; Lahkar, M; Madhana, RM; Malik, A; Samudrala, PK; Singh, VB; Sinha, S | 1 |
Camargo, A; Colla, ARS; Lieberknecht, V; Pazini, FL; Rodrigues, ALS | 1 |
Gao, M; Guan, X; Li, L; Li, X; Liang, X; Liang, Y; Sun, C; Sun, X; Tang, M; Wang, W; Zhang, X; Zhao, S; Zu, Y | 1 |
Amiri, S; Gauvin, E; Peeri, M; Pirri, F; Zolfaghari, FS | 1 |
Brocardo, PS; Budni, J; Camargo, A; Fraga, DB; Mina, F; Olescowicz, G; Padilha, DA; Rodrigues, ALS | 1 |
Amigo, J; Castro, E; Compan, V; Díaz, A; Garro-Martinez, E; Pazos, A; Pilar-Cuéllar, F; Vidal Casado, R | 1 |
Galea, LAM; Go, KA; Lamers, Y; Qiu, W | 1 |
An, H; Chen, S; He, Z; Hu, B; Qi, D; Sun, Y; Wang, M; Wei, Y | 1 |
Cantero-García, N; Díaz-Cabiale, Z; Flores-Burgess, A; Fuxe, K; Gago, B; García-Durán, L; Millón, C; Narváez, JA; Puigcerver, A; Santín, L | 1 |
Becker, G; Bochi, GV; Camargo, LFM; da Silva Carlotto, M; Dos Santos, BM; Fialho, MFP; Oliveira, SM; Pereira, GC; Pillat, MM; Piton, E; Ramanzini, LG; Trevisan, G; Zanchet, EM | 1 |
Bhattacharjee, A; Nayak, PK; Shivavedi, N; Verma, H | 1 |
Akil, H; Anacker, C; Andreu, V; Arcego, DM; Carazo-Arias, E; Coie, L; Gergues, MM; Hen, R; Jee, HJ; Kalachikov, S; Kass, M; Khalil, H; Magalong, V; Meaney, M; Morozova, I; Nautiyal, KM; Nguyen, PT; Pintar, JE; Samuels, BA | 1 |
Chen, J; Hu, L; Peng, H; Yang, K; Zeng, X; Zhu, W | 1 |
Cheng, YT; Lu, Y; Pei, L; Sun, GQ; Wang, Z | 1 |
Butkevich, IP; Mikhailenko, VA; Vershinina, EA | 1 |
Graham, BM; Pestana, JE | 1 |
Betancur, C; Callebert, J; Gautron, S; Gruszczynski, C; Guiard, BP; Launay, JM; Louis, F; Manta, S; Orrico-Sanchez, A; Paccard, A; Vialou, V | 1 |
Adebayo, OG; Ben-Azu, B; Chidebe, EO; Chukwuma, C; Etijoro, E; Mamudu, EJ; Moke, EG; Nwangwa, EK; Omogbiya, AI; Oritsemuelebi, B; Umukoro, E | 1 |
Arikawe, AP; Costa, EA; Costa, RF; Fajemiroye, JO; Moreira, CVL; Napolitano, HB; Oliveira-Silva, I; Pedrino, GR; Prado, CC; Rodrigues, ACC; Silva, LSB; Silva, ON | 1 |
1 review(s) available for fluoxetine and corticosterone
Article | Year |
---|---|
Serotonergic stimulation of pituitary-adrenocortical function in rats.
Topics: 5-Hydroxytryptophan; Adrenal Cortex; Animals; Brain; Circadian Rhythm; Corticosterone; Corticotropin-Releasing Hormone; Fluoxetine; Hypothalamus; Metergoline; Neurons; p-Chloroamphetamine; Piperazines; Pituitary Gland; Receptors, Serotonin; Serotonin; Stress, Physiological | 1981 |
192 other study(ies) available for fluoxetine and corticosterone
Article | Year |
---|---|
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Polyprenylated Tetraoxygenated Xanthones from the Roots of Hypericum monogynum and Their Neuroprotective Activities.
Topics: Animals; Hypericum; Molecular Structure; Neuroprotective Agents; Nuclear Magnetic Resonance, Biomolecular; Plant Roots; Prenylation; Rats; Xanthones | 2016 |
The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
Topics: 5-Hydroxytryptophan; 5,7-Dihydroxytryptamine; Animals; Atropine; Corticosterone; Dose-Response Relationship, Drug; Fluoxetine; Male; Metergoline; Quinolines; Quipazine; Rats; Serotonin Antagonists | 1978 |
Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
Topics: Adaptation, Physiological; Animals; Behavior, Animal; Cerebral Cortex; Corticosterone; Dihydroalprenolol; Fluoxetine; Hippocampus; Imipramine; Ketanserin; Male; Physical Exertion; Rats; Rats, Inbred F344; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, GABA-A; Species Specificity; Swimming | 1990 |
Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Body Temperature; Corticosterone; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prolactin; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists | 1988 |
Pharmacological studies on the serotoninergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine. Effects of pretreatment with fluoxetine, indalpine, PCPA, and L-tryptophan.
Topics: Animals; Antidepressive Agents; Corticosterone; Fenclonine; Fenfluramine; Fluoxetine; Kinetics; Male; Piperidines; Prolactin; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Tryptophan | 1985 |
Differential ontogeny of opioid, dopaminergic and serotonergic regulation of prolactin secretion.
Topics: 5-Hydroxytryptophan; Aging; Animals; Animals, Newborn; Corticosterone; Cyproheptadine; Fluoxetine; Growth Hormone; Morphine; p-Chloroamphetamine; Piperazines; Prolactin; Propylamines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin | 1987 |
The pharmacologic profile of fluoxetine.
Topics: Aggression; Animals; Antidepressive Agents; Behavior, Animal; Brain; Cats; Corticosterone; Fluoxetine; In Vitro Techniques; Mice; Neurons; Norepinephrine; Pituitary-Adrenal System; Propylamines; Rats; Receptors, Adrenergic; Receptors, Histamine; Receptors, Muscarinic; Receptors, Serotonin; Serotonin; Synapses; Synaptosomes | 1985 |
Effects of subchronic administration of psychoactive substances on the circadian rhythm of urinary corticosterone excretion in rats.
Topics: Animals; Antidepressive Agents; Circadian Rhythm; Clorgyline; Corticosterone; Fluoxetine; Imipramine; Male; Maprotiline; Pargyline; Propylamines; Rats; Trimipramine | 1985 |
Fenfluramine, p-chloroamphetamine and p-fluoroamphetamine stimulation of pituitary-adrenocortical activity in rat: evidence for differences in site and mechanism of action.
Topics: Adrenocorticotropic Hormone; Amphetamines; Animals; Corticosterone; Fenfluramine; Fluoxetine; Male; Methysergide; p-Chloroamphetamine; Pituitary-Adrenal System; Rats; Receptors, Serotonin; Serotonin | 1984 |
Effect of serotonin-releasing drugs on serum corticosterone concentration in rats.
Topics: Amphetamines; Animals; Corticosterone; Fenclonine; Fenfluramine; Fluoxetine; Male; p-Chloroamphetamine; Quipazine; Rats; Serotonin | 1980 |
Effects of naloxone on the secretion of prolactin and corticosterone induced by 5-hydroxytryptophan and a serotonergic agonist, mCPP.
Topics: 5-Hydroxytryptophan; Animals; Corticosterone; Fluoxetine; Male; Naloxone; Piperazines; Prolactin; Rats; Rats, Inbred Strains | 1983 |
Effect of fluoxetine and metergoline on amphetamine-induced rise in plasma corticosterone.
Topics: Amphetamine; Animals; Corticosterone; Ergolines; Fluoxetine; Kinetics; Male; Metergoline; Propylamines; Rats | 1980 |
Serotonin regulation of corticoid secretion in infant rats.
Topics: 5-Hydroxytryptophan; Adrenal Cortex; Animals; Animals, Newborn; Carbidopa; Corticosterone; Dose-Response Relationship, Drug; Fluoxetine; Rats; Serotonin; Weaning | 1981 |
Fluoxetine reduces inflammatory edema in the rat: involvement of the pituitary-adrenal axis.
Topics: Adrenalectomy; Animals; beta-Endorphin; Corticosterone; Dose-Response Relationship, Drug; Edema; Fluoxetine; Hypophysectomy; Hypothalamo-Hypophyseal System; Inflammation; Male; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley | 1994 |
Serum corticosterone increases reflect enhanced uptake inhibitor-induced elevation of extracellular 5-hydroxytryptamine in rat hypothalamus.
Topics: 5-Hydroxytryptophan; Animals; Corticosterone; Cyclohexylamines; Drug Synergism; Fluoxetine; Hypothalamus; Injections, Subcutaneous; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1996 |
Fluoxetine-induced desensitization of somatodendritic 5-HT1A autoreceptors is independent of glucocorticoid(s).
Topics: Adrenal Glands; Adrenalectomy; Animals; Antidepressive Agents, Second-Generation; Autoreceptors; Corticosterone; Dendrites; Fluoxetine; Glucocorticoids; In Vitro Techniques; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 1997 |
Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone.
Topics: Animals; Antidepressive Agents; Corticosterone; Fluoxetine; Imipramine; Male; Phenelzine; Progesterone; Rats; Rats, Sprague-Dawley; Stress, Physiological; Swimming | 1998 |
Functional consequences of central serotonin depletion produced by repeated fenfluramine administration in rats.
Topics: Animals; Behavior, Animal; Body Weight; Brain; Corticosterone; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetine; Male; Prolactin; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors | 1998 |
Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Brain; Corticosterone; Dominance-Subordination; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Neurosecretory Systems; Pituitary-Adrenal System; Rats; Rats, Inbred Lew; Renin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists; Stress, Psychological; Tryptophan | 1999 |
An investigation of serotonergic involvement in the regulation of ACTH and corticosterone in the olfactory bulbectomized rat.
Topics: Adrenocorticotropic Hormone; Amygdala; Animals; Chromatography, High Pressure Liquid; Corticosterone; Fluoxetine; Hydroxyindoleacetic Acid; Hypothalamus; Male; Olfactory Bulb; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological | 1999 |
Long-term fluoxetine produces behavioral anxiolytic effects without inhibiting neuroendocrine responses to conditioned stress in rats.
Topics: Adrenocorticotropic Hormone; Animals; Anxiety; Behavior, Animal; Body Weight; Conditioning, Psychological; Corticosterone; Defecation; Fluoxetine; Male; Neurosecretory Systems; Oxytocin; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Renin; Selective Serotonin Reuptake Inhibitors; Stress, Physiological | 2000 |
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Animals; Body Temperature; Columbidae; Corticosterone; Depression; Discrimination Learning; Drug Interactions; Fluoxetine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Lip; Male; Microdialysis; Neurons; Nicotine; Piperidines; Posture; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Smoking Cessation; Substance Withdrawal Syndrome; Sulfur Radioisotopes | 2000 |
Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-L-tryptophan or fluoxetine.
Topics: 5-Hydroxytryptophan; Administration, Oral; Adrenalectomy; Animals; Binding Sites; Brain Stem; Central Nervous System; Corticosterone; Fluoxetine; Hippocampus; Hydroxyindoleacetic Acid; Hypothalamus; Male; Occipital Lobe; Rats; Receptors, Mineralocorticoid; Receptors, Steroid; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission | 2000 |
Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents.
Topics: Adrenal Glands; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Body Temperature; Brain; Corticosterone; Cytokines; Drug Administration Schedule; Drug Interactions; Fluoxetine; Hypothalamo-Hypophyseal System; Imipramine; Immune System; Lipopolysaccharides; Male; Neuroimmunomodulation; Rats; Rats, Inbred F344; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Spleen | 2001 |
Short-term administration of fluoxetine and venlafaxine decreases corticosteroid receptor mRNA expression in the rat hippocampus.
Topics: Animals; Antidepressive Agents, Second-Generation; Corticosterone; Cyclohexanols; Fluoxetine; Gene Expression; Hippocampus; Male; Maze Learning; Memory; Rats; Rats, Inbred Strains; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; RNA, Messenger; Venlafaxine Hydrochloride | 2001 |
Opposite effects of short- versus long-term administration of fluoxetine on the concentrations of neuroactive steroids in rat plasma and brain.
Topics: Animals; Cerebral Cortex; Corticosterone; Drug Administration Schedule; Fluoxetine; Injections, Intraperitoneal; Male; Pregnenolone; Progesterone; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Steroids; Stress, Physiological | 2001 |
cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Corticosterone; Crosses, Genetic; Cyclic AMP Response Element-Binding Protein; Desipramine; Endocrine System; Exercise Test; Fluoxetine; Mice; Mice, Inbred Strains; Mice, Mutant Strains; Motor Activity; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Transcription, Genetic; Up-Regulation | 2002 |
Overcoming the effects of stress on synaptic plasticity in the intact hippocampus: rapid actions of serotonergic and antidepressant agents.
Topics: Animals; Antidepressive Agents; Corticosterone; Drug Antagonism; Electrodes, Implanted; Excitatory Postsynaptic Potentials; Exercise Test; Fenfluramine; Fluoxetine; Hippocampus; Long-Term Potentiation; Male; Neuronal Plasticity; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Stress, Physiological; Synapses; Thiazepines | 2002 |
Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Body Weight; Corticosterone; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drug Interactions; Estrous Cycle; Female; Fluoxetine; Hypothalamus; Pituitary Hormones; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Receptor Agonists | 2002 |
Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Animals; Body Weight; Cerebral Cortex; Corticosterone; Dose-Response Relationship, Drug; Fluoxetine; Hypothalamus; Injections, Intraventricular; Male; Oxytocin; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin | 2002 |
Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Bromodeoxyuridine; Cell Count; Cell Division; Conditioning, Operant; Corticosterone; Depression; Disease Models, Animal; Electroshock; Escape Reaction; Fluoxetine; Helplessness, Learned; Hippocampus; Male; Nerve Growth Factors; Nuclear Proteins; Radiation-Sensitizing Agents; Rats; Rats, Sprague-Dawley; Reaction Time; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Stress, Psychological; Time Factors | 2003 |
Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters.
Topics: Animals; Antidepressive Agents, Second-Generation; Caco-2 Cells; Corticosterone; Fluoxetine; Humans; Hydrocortisone; Membrane Transport Modulators; Membrane Transport Proteins; Mice; Receptors, Glucocorticoid; Steroids | 2003 |
Cytoprotective effect is one of common action pathways for antidepressants.
Topics: Animals; Anticonvulsants; Calcium; Cell Survival; Corticosterone; Desipramine; Fluoxetine; Moclobemide; Nerve Growth Factor; Neuroprotective Agents; PC12 Cells; Rats; RNA, Messenger | 2003 |
Characterization of fluoxetine plus olanzapine treatment in rats: a behavior, endocrine, and immediate-early gene expression analysis.
Topics: Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Blood Glucose; Blotting, Western; Body Weight; Corticosterone; Cyclic AMP Response Element-Binding Protein; Drug Interactions; Fluoxetine; Gene Expression; Genes, Immediate-Early; Hippocampus; Immunohistochemistry; Male; Mitogen-Activated Protein Kinases; Movement; Olanzapine; Pirenzepine; Proto-Oncogene Proteins c-fos; Rats; Rats, Long-Evans; Time Factors | 2003 |
Effects of fluoxetine on social behaviour and plasma corticosteroid levels in female Mongolian gerbils.
Topics: Animals; Arousal; Corticosterone; Dose-Response Relationship, Drug; Female; Fluoxetine; Gerbillinae; Male; Motivation; Motor Activity; Psychosocial Deprivation; Selective Serotonin Reuptake Inhibitors; Social Behavior; Social Environment; Social Isolation | 2003 |
Fluoxetine-induced changes in body weight and 5-HT1A receptor-mediated hormone secretion in rats on a tryptophan-deficient diet.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Animals; Body Weight; Brain; Corticosterone; Diet; Fluoxetine; Hormones; Male; Neurosecretory Systems; Oxytocin; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Tryptophan | 2004 |
Fluoxetine treatment of prepubescent rats produces a selective functional reduction in the 5-HT2A receptor-mediated stimulation of oxytocin.
Topics: Adrenocorticotropic Hormone; Aging; Animals; Body Weight; Brain; Corticosterone; Dose-Response Relationship, Drug; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Neurosecretory Systems; Oxytocin; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Renin; Reproduction; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Up-Regulation | 2005 |
Time-dependent behavioral, neurochemical, and immune consequences of repeated experiences of social defeat stress in male mice and the ameliorative effects of fluoxetine.
Topics: Analysis of Variance; Animals; Cell Proliferation; Corticosterone; Dominance-Subordination; Dopamine; Fluoxetine; Hypothalamus; Immunity, Cellular; Interpersonal Relations; Male; Mice; Monocytes; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological; Time Factors | 2005 |
Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone.
Topics: Age Factors; Aging; Animals; Cell Proliferation; Corticosterone; Dentate Gyrus; Depressive Disorder, Major; Disease Models, Animal; Fluoxetine; Hippocampus; Male; Periodicity; Rats; Selective Serotonin Reuptake Inhibitors; Stem Cells | 2006 |
Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone.
Topics: Animals; Antidepressive Agents; Brain; Brain-Derived Neurotrophic Factor; Corticosterone; Desipramine; Drug Implants; Exons; Fluoxetine; Gene Expression; Male; Phenelzine; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic | 2006 |
Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress.
Topics: Animals; Base Sequence; Brain-Derived Neurotrophic Factor; Chronic Disease; Corticosterone; Cyclic AMP Response Element-Binding Protein; DNA Primers; Fluoxetine; Imipramine; Learning; Male; Memory; Mice; Mice, Inbred ICR; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stress, Physiological | 2006 |
Hippocampal cell proliferation regulation by repeated stress and antidepressants.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Bromodeoxyuridine; Cell Count; Cell Proliferation; Corticosterone; Desipramine; Electroshock; Fluoxetine; Helplessness, Learned; Hippocampus; Immunohistochemistry; Male; Neurons; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2006 |
Olanzapine and fluoxetine administration and coadministration increase rat hippocampal pregnenolone, allopregnanolone and peripheral deoxycorticosterone: implications for therapeutic actions.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Chromatography, High Pressure Liquid; Corticosterone; Desoxycorticosterone; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Gas Chromatography-Mass Spectrometry; Hippocampus; Male; Olanzapine; Pregnanolone; Pregnenolone; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2006 |
Adrenalectomy-induced granule cell degeneration in the hippocampus causes spatial memory deficits that are not reversed by chronic treatment with corticosterone or fluoxetine.
Topics: Adrenalectomy; Animals; Biomarkers; Cell Count; Corticosterone; Cytoplasmic Granules; Doublecortin Domain Proteins; Doublecortin Protein; Fluoxetine; Hippocampus; Immunohistochemistry; Ki-67 Antigen; Male; Maze Learning; Memory Disorders; Microtubule-Associated Proteins; Nerve Degeneration; Neuropeptides; Rats; Rats, Long-Evans; Selective Serotonin Reuptake Inhibitors; Space Perception | 2007 |
Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Bromodeoxyuridine; Cell Proliferation; Cerebral Cortex; Conditioning, Operant; Corticosterone; Disease Models, Animal; Fluoxetine; Ki-67 Antigen; Male; Neuroglia; Neurons; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2007 |
Antidepressant drugs reverse the loss of adult neural stem cells following chronic stress.
Topics: Animals; Antidepressive Agents; Biological Assay; Cell Death; Cells, Cultured; Chronic Disease; Corticosterone; Disease Models, Animal; Fluoxetine; Glucocorticoids; Imipramine; Lateral Ventricles; Male; Mice; Mice, Inbred ICR; Nerve Degeneration; Olfactory Bulb; Selective Serotonin Reuptake Inhibitors; Serotonin; Spheroids, Cellular; Stem Cells; Stress, Psychological; Swimming; Telencephalon | 2007 |
Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression.
Topics: Amitriptyline; Animals; Anti-Inflammatory Agents; Antidepressive Agents, Tricyclic; Chronic Disease; Conditioning, Operant; Corticosterone; CREB-Binding Protein; Dentate Gyrus; Depressive Disorder, Major; Disease Models, Animal; Endoplasmic Reticulum Chaperone BiP; Extracellular Signal-Regulated MAP Kinases; Fluoxetine; Heat-Shock Proteins; Hippocampus; Locomotion; Mice; Mice, Inbred C57BL; Molecular Chaperones; Motivation; Selective Serotonin Reuptake Inhibitors | 2008 |
[Involvement of striatal serotonin in fluoxetine effects on adrenocortical function and behaviour].
Topics: Adrenal Cortex; Animals; Behavior, Animal; Corpus Striatum; Corticosterone; Fluoxetine; Glycyrrhizic Acid; Male; Maze Learning; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin | 2007 |
Effects of noradrenaline and serotonin reuptake inhibitors on pituitary-adrenocortical and sympatho-adrenomedullar system of adult rats.
Topics: Adrenal Medulla; Adrenergic Uptake Inhibitors; Adrenocorticotropic Hormone; Analysis of Variance; Animals; Corticosterone; Epinephrine; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Maprotiline; Norepinephrine; Pituitary-Adrenal System; Random Allocation; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Sympathetic Nervous System | 2007 |
The role of the arginine vasopressin Avp1b receptor in the acute neuroendocrine action of antidepressants.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Arginine Vasopressin; Corticosterone; Corticotropin-Releasing Hormone; Desipramine; Female; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Knockout; Oxytocin; Paraventricular Hypothalamic Nucleus; Pituitary-Adrenal System; Receptors, Vasopressin; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Sex Factors | 2008 |
Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice.
Topics: Adrenal Glands; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antimetabolites; Anxiety; Behavior, Animal; Bromodeoxyuridine; Cell Proliferation; Chemistry, Pharmaceutical; Corticosterone; Depression; Fluoxetine; Hippocampus; Imipramine; Immunohistochemistry; Lighting; Male; Mice; Organ Size; Swimming | 2008 |
Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: evidence from sleep, stress, and behavior.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents; Behavior, Animal; Choice Behavior; Citalopram; Corticosterone; Depressive Disorder; Disease Models, Animal; Fluoxetine; Food Preferences; Hypothermia; Maze Learning; Mice; Mice, Knockout; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sleep Wake Disorders; Spectrum Analysis; Stress, Physiological; Wakefulness | 2008 |
Inter-individual differences in novelty-seeking behavior in rats predict differential responses to desipramine in the forced swim test.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain Chemistry; Corticosterone; Depressive Disorder; Desipramine; Exploratory Behavior; Fluoxetine; Genes, fos; Image Processing, Computer-Assisted; In Situ Hybridization; Individuality; Male; Motor Activity; Rats; Rats, Sprague-Dawley; RNA, Messenger; Swimming | 2008 |
Effects of adolescent fluoxetine treatment on fear-, anxiety- or stress-related behaviors in C57BL/6J or BALB/cJ mice.
Topics: Age Factors; Animals; Antidepressive Agents, Second-Generation; Arousal; Behavior, Animal; Conditioning, Classical; Corticosterone; Dose-Response Relationship, Drug; Exploratory Behavior; Extinction, Psychological; Fear; Fluoxetine; Frontal Lobe; Hippocampus; Hydroxyindoleacetic Acid; Male; Maze Learning; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Motivation; Motor Activity; Serotonin; Social Environment; Species Specificity | 2008 |
Strain differences in proliferation of progenitor cells in the dentate gyrus of the adult rat and the response to fluoxetine are dependent on corticosterone.
Topics: Adrenalectomy; Adult Stem Cells; Analysis of Variance; Animals; Cell Count; Cell Proliferation; Corticosterone; Dentate Gyrus; Drug Delivery Systems; Fluoxetine; Ki-67 Antigen; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Species Specificity | 2008 |
Fluoxetine inhibits corticotropin-releasing factor (CRF)-induced behavioural responses in rats.
Topics: Animals; Arousal; Behavior, Animal; Corticosterone; Corticotropin-Releasing Hormone; Fluoxetine; Hydroxyindoleacetic Acid; Injections, Intraventricular; Locomotion; Male; Motor Activity; Prosencephalon; Rats; Rats, Wistar; Serotonin | 2009 |
Synergistic effects of dehydroepiandrosterone and fluoxetine on proliferation of progenitor cells in the dentate gyrus of the adult male rat.
Topics: Adjuvants, Immunologic; Adult Stem Cells; Analysis of Variance; Animals; Cell Count; Cell Proliferation; Corticosterone; Dehydroepiandrosterone; Dentate Gyrus; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Ki-67 Antigen; Male; Neurogenesis; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2009 |
Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats.
Topics: Adenylyl Cyclases; Analysis of Variance; Animals; Antidepressive Agents; Body Weight; Brain; Corticosterone; Curcumin; Cyclic AMP; Disease Models, Animal; Dose-Response Relationship, Drug; Drinking; Eating; Fluoxetine; Food Deprivation; Food Preferences; Male; Rats; Rats, Wistar; Receptors, Serotonin; RNA, Messenger; Serotonin; Signal Transduction; Stress, Psychological; Up-Regulation; Water Deprivation | 2009 |
Fluoxetine potentiates the effects of corticotropin-releasing factor on locomotor activity and serotonergic systems in the roughskin newt, Taricha granulosa.
Topics: Animals; Chromatography, High Pressure Liquid; Corticosterone; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Fluoxetine; Hydroxyindoleacetic Acid; Male; Motor Activity; Prosencephalon; Radioimmunoassay; Salamandridae; Selective Serotonin Reuptake Inhibitors; Serotonin | 2009 |
Pre-exposure to environmental cues predictive of food availability elicits hypothalamic-pituitary-adrenal axis activation and increases operant responding for food in female rats.
Topics: Adrenocorticotropic Hormone; Animals; Anti-Obesity Agents; Appetite Depressants; Cannabinoids; Conditioning, Operant; Corticosterone; Cues; Cyclobutanes; Environment; Feeding Behavior; Female; Fluoxetine; Fructose; Humans; Hypothalamo-Hypophyseal System; Motivation; Piperidines; Pituitary-Adrenal System; Pyrazoles; Rats; Reproducibility of Results; Rimonabant; Selective Serotonin Reuptake Inhibitors; Topiramate | 2009 |
Dissecting the pathophysiology of depression with a Swiss army knife.
Topics: Animals; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Hippocampus; Humans; Neurogenesis; Selective Serotonin Reuptake Inhibitors | 2009 |
Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Anxiety; Arrestins; beta-Arrestin 2; beta-Arrestins; Bromodeoxyuridine; Cell Proliferation; Cell Survival; Corticosterone; Depression; Disease Models, Animal; Doublecortin Domain Proteins; Drug Administration Schedule; Exploratory Behavior; Feeding Behavior; Fluoxetine; Gene Expression Regulation; GTP-Binding Protein alpha Subunit, Gi2; Hippocampus; Hypothalamus; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Radiation; Reaction Time; RNA, Messenger | 2009 |
Prozac during puberty: distinctive effects on neurogenesis as a function of age and sex.
Topics: Aging; Animals; Antidepressive Agents, Second-Generation; Bromodeoxyuridine; Cell Proliferation; Cell Survival; Corticosterone; Female; Fluoxetine; Male; Neurogenesis; Random Allocation; Rats; Rats, Sprague-Dawley; Sex Characteristics; Sexual Maturation; Time Factors | 2009 |
The lonely mouse: verification of a separation-induced model of depression in female mice.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Conditioning, Classical; Corticosterone; Depression; Disease Models, Animal; Exploratory Behavior; Fear; Female; Fluoxetine; Freezing Reaction, Cataleptic; Hindlimb Suspension; Housing, Animal; Mice; Sensory Gating; Social Environment; Social Isolation; Stress, Psychological; Time Factors | 2010 |
Shaping brain development: mouse communal nesting blunts adult neuroendocrine and behavioral response to social stress and modifies chronic antidepressant treatment outcome.
Topics: Animals; Behavior, Animal; Brain; Corticosterone; Depression; Drug Administration Schedule; Female; Fluoxetine; Food Preferences; Male; Mice; Mice, Inbred ICR; Nesting Behavior; Social Environment; Stress, Psychological; Swimming | 2010 |
Nerve growth factor (NGF) has novel antidepressant-like properties in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Corticosterone; Desipramine; Disease Models, Animal; Drug Interactions; Fluoxetine; Hypothermia; Motor Activity; Nerve Growth Factor; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Serotonin Agents; Social Behavior; Swimming | 2010 |
Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors.
Topics: Acoustic Stimulation; Animals; Antidepressive Agents, Second-Generation; Anxiety; Bromodeoxyuridine; C-Reactive Protein; Cell Proliferation; Conditioning, Psychological; Corticosterone; Depression; Disease Models, Animal; Fear; Fluoxetine; Hippocampus; Macrophage Migration-Inhibitory Factors; Maze Learning; Memory Disorders; Mice; Mice, Knockout; Microscopy, Confocal; Nerve Tissue Proteins; Neurogenesis; Rats; Rats, Wistar; Receptors, Steroid; Spatial Behavior | 2011 |
Circadian activity of corticosterone in an animal model of depression: response to muscarinic cholinergic stimulation.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Behavior, Animal; Cholinergic Agonists; Circadian Rhythm; Clomipramine; Corticosterone; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Muscarinic Agonists; Oxotremorine; Pituitary-Adrenal System; Rats; Rats, Wistar; Time Factors | 2010 |
gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Depressive Disorder; Desipramine; Disease Models, Animal; Female; Fluoxetine; Hypothalamo-Hypophyseal System; Mice; Mice, Knockout; Pituitary-Adrenal System; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors | 2010 |
Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine.
Topics: Adrenocorticotropic Hormone; Animals; Corticosterone; Disease Models, Animal; Drug Evaluation, Preclinical; Emotions; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Morphine; Morphine Dependence; Prosencephalon; Raphe Nuclei; Serotonin; Social Behavior; Substance Withdrawal Syndrome; Time Factors | 2011 |
Icariin attenuates social defeat-induced down-regulation of glucocorticoid receptor in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Down-Regulation; Drugs, Chinese Herbal; Flavonoids; Fluoxetine; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Receptors, Glucocorticoid; Social Behavior | 2011 |
Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Citalopram; Corticosterone; Diazepam; Drug Interactions; Fluoxetine; Male; Mice; Mice, Inbred BALB C; Selective Serotonin Reuptake Inhibitors | 2011 |
Beneficial behavioural and neurogenic effects of agomelatine in a model of depression/anxiety.
Topics: Acetamides; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Cell Proliferation; Circadian Rhythm; Corticosterone; Dendrites; Depressive Disorder; Disease Models, Animal; Fluoxetine; Hippocampus; Male; Mice, Inbred C57BL; Motor Activity; Neurogenesis; Neurons; Serotonin 5-HT2 Receptor Antagonists | 2012 |
Antidepressants recruit new neurons to improve stress response regulation.
Topics: Animals; Antidepressive Agents; Cell Count; Corticosterone; Depression; Dexamethasone; Disease Models, Animal; Fluoxetine; Hippocampus; Humans; Hydrocarbons, Halogenated; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred BALB C; Neurogenesis; Pituitary-Adrenal Function Tests; Pituitary-Adrenal System; Radiography; Stress, Psychological; Thiazines | 2011 |
Curcumin prevents corticosterone-induced neurotoxicity and abnormalities of neuroplasticity via 5-HT receptor pathway.
Topics: Analysis of Variance; Animals; Animals, Newborn; Anti-Inflammatory Agents; Cell Survival; Cells, Cultured; Cerebral Cortex; Corticosterone; CREB-Binding Protein; Curcumin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Fluoxetine; Gene Expression Regulation; Neuronal Plasticity; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Serotonin, 5-HT1; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Transfection | 2011 |
Metyrapone and fluoxetine suppress enduring behavioral but not cardiac effects of subchronic stress in rats.
Topics: Animals; Behavior, Animal; Circadian Rhythm; Corticosterone; Electric Stimulation; Fluoxetine; Heart Rate; Male; Metyrapone; Models, Animal; Motor Activity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Physiological; Vagus Nerve | 2011 |
Social stress-induced hypothyroidism is attenuated by antidepressant treatment in rats.
Topics: Adipose Tissue, Brown; Analysis of Variance; Animals; Antidepressive Agents; Body Weight; Corticosterone; Disease Models, Animal; Exploratory Behavior; Fluoxetine; Food Preferences; Hypothyroidism; Male; Organ Size; Radioimmunoassay; Rats; Rats, Wistar; Social Behavior; Stress, Psychological; Sucrose; Thyroxine; Time Factors; Triiodothyronine | 2012 |
Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Body Weight; Central Nervous System Stimulants; Chlordiazepoxide; Corticosterone; Disease Models, Animal; Emotions; Exploratory Behavior; Fluoxetine; Light; Lithium Chloride; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Restraint, Physical; Stress, Psychological; Swimming | 2012 |
Effects of periadolescent fluoxetine and paroxetine on elevated plus-maze, acoustic startle, and swimming immobility in rats while on and off-drug.
Topics: Acoustic Stimulation; Age Factors; Analysis of Variance; Animals; Body Weight; Brain; Corticosterone; Critical Period, Psychological; Dose-Response Relationship, Drug; Escape Reaction; Exploratory Behavior; Fluoxetine; Immobility Response, Tonic; Longitudinal Studies; Male; Maze Learning; Paroxetine; Rats; Reflex, Startle; Selective Serotonin Reuptake Inhibitors; Sensory Gating | 2011 |
Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration.
Topics: Animals; Anxiety; Autoreceptors; Corticosterone; Depression; Drug Resistance; Drug Therapy, Combination; Fluoxetine; Mice; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors | 2012 |
Peony glycosides reverse the effects of corticosterone on behavior and brain BDNF expression in rats.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Corticosterone; Depression; Disease Models, Animal; Drug Interactions; Fluoxetine; Food Preferences; Glycosides; Immobility Response, Tonic; Male; Paeonia; Phytotherapy; Rats; Rats, Sprague-Dawley; Sucrose; Sweetening Agents | 2012 |
Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress.
Topics: Animals; Antidepressive Agents; Antioxidants; Ascorbic Acid; Catalase; Cerebral Cortex; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Glutathione; Glutathione Reductase; Hippocampus; Lipid Peroxidation; Mice; Motor Activity; Oxidative Stress; Stress, Psychological; Treatment Outcome | 2012 |
Chronic fluoxetine treatment and maternal adversity differentially alter neurobehavioral outcomes in the rat dam.
Topics: Animals; Antidepressive Agents, Second-Generation; Cell Count; Corticosterone; Disease Models, Animal; Drug Administration Schedule; Female; Fluoxetine; Hippocampus; Immobility Response, Tonic; Male; Maternal Behavior; Maze Learning; Motor Activity; Neurogenesis; Pregnancy; Pregnancy Complications; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stress, Psychological; Transcortin | 2012 |
Prenatal lipopolysaccharide exposure increases anxiety-like behaviors and enhances stress-induced corticosterone responses in adult rats.
Topics: Animals; Anxiety; Anxiety Disorders; Brain; Corticosterone; Dopamine; Female; Fluoxetine; Hippocampus; Hypothalamo-Hypophyseal System; Lipopolysaccharides; Models, Animal; Pituitary-Adrenal System; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Serotonin; Stress, Psychological | 2012 |
Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes.
Topics: Amygdala; Analysis of Variance; Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; Autonomic Nervous System Diseases; Avoidance Learning; Corticosterone; Dendrites; Discrimination, Psychological; Disease Models, Animal; Electrocardiography; Endocrine System Diseases; Extinction, Psychological; Fear; Fluoxetine; Humans; Inhibition, Psychological; Male; Mice; Mice, Inbred Strains; Receptors, Glucocorticoid; RNA, Messenger; Telemetry | 2012 |
Antidepressant-like activity of gallic acid in mice subjected to unpredictable chronic mild stress.
Topics: Animals; Antidepressive Agents; Antioxidants; Brain; Catalase; Corticosterone; Depression; Fluoxetine; Gallic Acid; Glutathione; Male; Malondialdehyde; Mice; Monoamine Oxidase; Motor Activity; Nitrites; Stress, Physiological; Sucrose; Swimming | 2013 |
Antinociceptive effects of fluoxetine in a mouse model of anxiety/depression.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Chronic Pain; Cold Temperature; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Hot Temperature; Hyperalgesia; Male; Mice; Nociception | 2012 |
Chronic effects of corticosterone on GIRK1-3 subunits and 5-HT1A receptor expression in rat brain and their reversal by concurrent fluoxetine treatment.
Topics: Animals; Autoradiography; Corticosterone; Dentate Gyrus; Depressive Disorder, Major; Fluoxetine; G Protein-Coupled Inwardly-Rectifying Potassium Channels; Gene Expression; Gene Expression Profiling; Hippocampus; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Selective Serotonin Reuptake Inhibitors; Thalamus | 2013 |
Deletion of CREB-regulated transcription coactivator 1 induces pathological aggression, depression-related behaviors, and neuroplasticity genes dysregulation in mice.
Topics: Aggression; Animals; Antidepressive Agents, Second-Generation; Arabidopsis Proteins; Biogenic Monoamines; Brain; Brain-Derived Neurotrophic Factor; Chromatography, High Pressure Liquid; Corticosterone; Depressive Disorder; Disease Models, Animal; Electroshock; Enzyme-Linked Immunosorbent Assay; Exploratory Behavior; Fear; Female; Fluoxetine; Food Preferences; Gene Expression Regulation; Hindlimb Suspension; Intramolecular Transferases; Male; Maternal Behavior; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Nesting Behavior; Neuronal Plasticity; Orphan Nuclear Receptors; Receptor, trkB; Sexual Behavior, Animal; Signal Transduction; Social Behavior; Swimming; Transcription Factors | 2012 |
Neurobiological sequelae of witnessing stressful events in adult mice.
Topics: Animals; Anxiety; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Gene Expression Profiling; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Photic Stimulation; Social Behavior; Stress, Physiological; Stress, Psychological; Ventral Tegmental Area | 2013 |
Fluoxetine reverses depressive-like behaviors and increases hippocampal acetylcholinesterase activity induced by olfactory bulbectomy.
Topics: Acetylcholinesterase; Animals; Behavior, Animal; Corticosterone; Enzyme-Linked Immunosorbent Assay; Female; Fluoxetine; Hippocampus; Mice; Olfactory Bulb; Selective Serotonin Reuptake Inhibitors | 2012 |
Adolescence fluoxetine increases serotonergic activity in the raphe-hippocampus axis and improves depression-like behaviors in female rats that experienced neonatal maternal separation.
Topics: Animals; Animals, Newborn; Behavior, Animal; Body Weight; Corticosterone; Corticotropin-Releasing Hormone; Depression; Eating; Feeding and Eating Disorders; Female; Fluoxetine; Hippocampus; Hypothalamus; Maternal Deprivation; Raphe Nuclei; Rats; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2013 |
Aberrant light directly impairs mood and learning through melanopsin-expressing neurons.
Topics: Affect; Animals; Antidepressive Agents; Body Temperature Regulation; Circadian Rhythm; Cognition; Corticosterone; Depression; Desipramine; Fluoxetine; Learning; Light; Long-Term Potentiation; Male; Memory; Mice; Photoperiod; Retinal Ganglion Cells; Rod Opsins; Sleep; Wakefulness | 2012 |
Bidirectional crosstalk between stress-induced gastric ulcer and depression under chronic stress.
Topics: Animals; Anti-Ulcer Agents; Corticosterone; Depression; Fluoxetine; Male; Mifepristone; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Psychological | 2012 |
Impacts of early intervention with fluoxetine following early neonatal immune activation on depression-like behaviors and body weight in mice.
Topics: Aging; Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Behavior, Animal; Body Weight; Corticosterone; Depression; Female; Fluoxetine; Hindlimb Suspension; Immune System; Lipopolysaccharides; Male; Mice; Motor Activity; Swimming | 2013 |
Differential effects of chronic social stress and fluoxetine on meal patterns in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Chronic Disease; Corticosterone; Eating; Energy Intake; Fluoxetine; Ghrelin; Leptin; Meals; Mice; Obesity; Satiation; Selective Serotonin Reuptake Inhibitors; Social Environment; Stress, Psychological | 2013 |
Gender-specific effects of fluoxetine on hippocampal glucocorticoid receptor phosphorylation and behavior in chronically stressed rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain-Derived Neurotrophic Factor; Cell Nucleus; Corticosterone; Cyclin-Dependent Kinase 5; Female; Fluoxetine; Gene Expression; Hippocampus; Immobility Response, Tonic; JNK Mitogen-Activated Protein Kinases; Male; Phosphorylation; Rats; Receptors, Glucocorticoid; Sex Characteristics; Signal Transduction; Social Isolation; Stress, Psychological | 2013 |
Effect of co-treatment with fluoxetine or mirtazapine and risperidone on the active behaviors and plasma corticosterone concentration in rats subjected to the forced swim test.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Exploratory Behavior; Fluoxetine; Male; Mianserin; Mirtazapine; Motor Activity; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Swimming | 2012 |
Ethopharmacological analysis of the open elevated plus-maze in mice.
Topics: Adrenergic alpha-2 Receptor Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Convulsants; Corticosterone; Diazepam; Factor Analysis, Statistical; Fluoxetine; Male; Maze Learning; Mice; Pentylenetetrazole; Statistics, Nonparametric; Yohimbine | 2013 |
Antidepressant treatment outcome depends on the quality of the living environment: a pre-clinical investigation in mice.
Topics: Anhedonia; Animals; Antidepressive Agents; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Corticosterone; Depressive Disorder, Major; Drug Evaluation, Preclinical; Environment; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological; Treatment Outcome | 2013 |
[Effect of hesperidin on behavior and HPA axis of rat model of chronic stress-induced depression].
Topics: Administration, Oral; Animals; Behavior, Animal; Corticosterone; Corticotropin-Releasing Hormone; Depression; Fluoxetine; Gene Expression Regulation; Hesperidin; Hypothalamo-Hypophyseal System; Hypothalamus; Male; Models, Animal; Pituitary-Adrenal System; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Stress, Psychological; Sucrose; Swimming; Up-Regulation | 2013 |
Corticosterone facilitates fluoxetine-induced neuronal plasticity in the hippocampus.
Topics: Animals; Corticosterone; Fluoxetine; Hippocampus; Male; Mice; Neuronal Plasticity; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission | 2013 |
Systematic correlation between spine plasticity and the anxiety/depression-like phenotype induced by corticosterone in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; CA1 Region, Hippocampal; Corticosterone; Dendritic Spines; Depression; Disease Models, Animal; Female; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Neuronal Plasticity; Phenotype | 2013 |
Rapid anxiolytic effects of a 5-HT₄ receptor agonist are mediated by a neurogenesis-independent mechanism.
Topics: Aniline Compounds; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Anxiety; Comorbidity; Corticosterone; Depressive Disorder; Disease Models, Animal; Fluoxetine; Hippocampus; Indoles; Male; Mice; Mice, Inbred C57BL; Neurogenesis; Neurons; Piperidines; Receptors, Serotonin, 5-HT4; Serotonin 5-HT4 Receptor Agonists; Serotonin 5-HT4 Receptor Antagonists; Sulfonamides; Time Factors | 2014 |
Chronic mild stress-induced changes of risk assessment behaviors in mice are prevented by chronic treatment with fluoxetine but not diazepam.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Chronic Disease; Corticosterone; Diazepam; Fluoxetine; Male; Mice; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2014 |
Functional dissociation of adult-born neurons along the dorsoventral axis of the dentate gyrus.
Topics: Adult Stem Cells; Animals; Anti-Anxiety Agents; Antidepressive Agents; Corticosterone; Cranial Irradiation; Dentate Gyrus; Discrimination Learning; Electroshock; Exploratory Behavior; Feeding Behavior; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Neurogenesis; Neurons; Swimming | 2014 |
Chronic corticosterone exposure persistently elevates the expression of memory-related genes in the lateral amygdala and enhances the consolidation of a Pavlovian fear memory.
Topics: Amygdala; Animals; Behavior, Animal; Corticosterone; Fear; Fluoxetine; Gene Expression Regulation; Genes, Immediate-Early; Male; Memory; Rats; Signal Transduction; Stress, Psychological; Synapses | 2014 |
Antidepressant-like effects of omega-3 fatty acids in postpartum model of depression in rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Cytokines; Depression, Postpartum; Disease Models, Animal; Estradiol; Fatty Acids, Omega-3; Female; Fish Oils; Fluoxetine; Hippocampus; Locomotion; Motor Activity; Ovariectomy; Postpartum Period; Pregnancy; Progesterone; Rats; Rats, Sprague-Dawley; Swimming | 2014 |
Behavioral and biochemical evidences for antidepressant-like activity of palmatine in mice subjected to chronic unpredictable mild stress.
Topics: Animals; Antidepressive Agents; Berberine Alkaloids; Brain; Chronic Disease; Corticosterone; Fluoxetine; Lipid Peroxidation; Male; Mice; Monoamine Oxidase; Motor Activity; Nitrites; Stress, Psychological | 2014 |
Effects of aspirin on immobile behavior and endocrine and immune changes in the forced swimming test: comparison to fluoxetine and imipramine.
Topics: Animals; Antidepressive Agents; Aspirin; Behavior, Animal; Corticosterone; Endocrine Glands; Fluoxetine; Imipramine; Immune System; Interleukin-6; Male; Rats; Rats, Sprague-Dawley; Swimming; Tumor Necrosis Factor-alpha | 2014 |
The antidepressant effects of ginseng total saponins in male C57BL/6N mice by enhancing hippocampal inhibitory phosphorylation of GSK-3β.
Topics: Animals; Antidepressive Agents; Corticosterone; Depression; Disease Models, Animal; Down-Regulation; Fluoxetine; Glycogen Synthase Kinase 3; Hippocampus; Male; Mice; Mice, Inbred C57BL; Panax; Phosphorylation; Saponins | 2014 |
Temporal variability of glucocorticoid receptor activity is functionally important for the therapeutic action of fluoxetine in the hippocampus.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Corticosterone; Fluoxetine; Hippocampus; Hypothalamo-Hypophyseal System; Male; Phosphorylation; Pituitary-Adrenal System; Rats; Rats, Wistar; Receptors, Glucocorticoid; Signal Transduction; Stress, Psychological | 2016 |
Behavioural and physiological responses of birds to environmentally relevant concentrations of an antidepressant.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Circadian Rhythm; Corticosterone; Feces; Female; Fluoxetine; Male; Monitoring, Physiologic; Starlings | 2014 |
Antidepressant-like effects of a novel 5-HT3 receptor antagonist 6z in acute and chronic murine models of depression.
Topics: Acute Disease; Animals; Antidepressive Agents; Antioxidants; Behavior, Animal; Benzothiazoles; Biomarkers; Brain; Chronic Disease; Corticosterone; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Feeding Behavior; Female; Fluoxetine; Guinea Pigs; Hypothalamo-Hypophyseal System; Ileum; Lipid Peroxidation; Male; Mice; Motor Activity; Oxidative Stress; Pituitary-Adrenal System; Quinoxalines; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists | 2014 |
Short-term fluoxetine treatment induces neuroendocrine and behavioral anxiogenic-like responses in adolescent male rats.
Topics: Animals; Anxiety; Behavior, Animal; Corticosterone; Dorsal Raphe Nucleus; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2015 |
Chronic unpredictable mild stress decreases BDNF and NGF levels and Na(+),K(+)-ATPase activity in the hippocampus and prefrontal cortex of mice: antidepressant effect of chrysin.
Topics: Animals; Antidepressive Agents; Antioxidants; Brain-Derived Neurotrophic Factor; Catalase; Chronic Disease; Corticosterone; Depressive Disorder; Disease Models, Animal; Female; Flavonoids; Fluoxetine; Glutathione Peroxidase; Glutathione Reductase; Hippocampus; Mice, Inbred C57BL; Nerve Growth Factor; Prefrontal Cortex; Sodium-Potassium-Exchanging ATPase; Stress, Psychological; Uncertainty; Up-Regulation | 2015 |
Antidepressant-like effects of oleoylethanolamide in a mouse model of chronic unpredictable mild stress.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents; Antioxidants; Atrophy; Brain-Derived Neurotrophic Factor; Corticosterone; Depression; Disease Models, Animal; Endocannabinoids; Fluoxetine; Hippocampus; Male; Malondialdehyde; Mice; Motor Activity; Oleic Acids; Prefrontal Cortex; Stress, Psychological; Superoxide Dismutase | 2015 |
Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety/depression.
Topics: Animals; Antidepressive Agents; Anxiety; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Corticosterone; Depression; Fluoxetine; Hippocampus; Male; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Signal Transduction | 2015 |
Effects of nitric oxide synthesis inhibitor or fluoxetine treatment on depression-like state and cardiovascular changes induced by chronic variable stress in rats.
Topics: Animals; Antidepressive Agents; Autonomic Nervous System; Baroreflex; Behavior, Animal; Cardiovascular System; Chronic Disease; Corticosterone; Depression; Enzyme Inhibitors; Fluoxetine; Indazoles; Male; Nitric Oxide Synthase Type I; Rats; Rats, Wistar; Stress, Psychological; Swimming; Vasoconstrictor Agents; Vasodilator Agents; Weight Gain | 2015 |
Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration.
Topics: Administration, Intranasal; Animals; Antidepressive Agents; Arabidopsis Proteins; Brain; Corticosterone; Depression; Disease Models, Animal; DNA, Antisense; Endocytosis; Exploratory Behavior; Fluoxetine; Gene Expression Regulation; Intramolecular Transferases; Male; Mice; Mice, Inbred C57BL; Neurons; Phosphopyruvate Hydratase; RNA, Small Interfering; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Time Factors | 2016 |
Alterations in circadian entrainment precede the onset of depression-like behavior that does not respond to fluoxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Circadian Rhythm; Corticosterone; Depression; Dexamethasone; Female; Fibroblasts; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects | 2015 |
Depressive-like behaviours and decreased dendritic branching in the medial prefrontal cortex of mice with tumors: A novel validated model of cancer-induced depression.
Topics: Anhedonia; Animals; Antidepressive Agents, Second-Generation; Cell Line, Tumor; Corticosterone; Dendrites; Depressive Disorder; Dietary Sucrose; Female; Fluoxetine; Mammary Neoplasms, Experimental; Mice, Inbred BALB C; Motor Activity; Neoplasm Transplantation; Prefrontal Cortex; Random Allocation | 2015 |
Preventive effects of ginsenoside Rg1 on post-traumatic stress disorder (PTSD)-like behavior in male C57/B6 mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Electroshock; Fluoxetine; Ginsenosides; Hypothalamus; Male; Maze Learning; Mice, Inbred C57BL; Neuroprotective Agents; Stress Disorders, Post-Traumatic | 2015 |
Maternal postpartum corticosterone and fluoxetine differentially affect adult male and female offspring on anxiety-like behavior, stress reactivity, and hippocampal neurogenesis.
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Anxiety; Corticosterone; Dexamethasone; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Exploratory Behavior; Female; Fluoxetine; Hippocampus; Male; Maze Learning; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Rats; Rats, Sprague-Dawley; Sex Factors; Stress, Psychological; Swimming | 2016 |
Geraniol produces antidepressant-like effects in a chronic unpredictable mild stress mice model.
Topics: Acyclic Monoterpenes; Animals; Antidepressive Agents; Carrier Proteins; Caspase 1; Chronic Disease; Corticosterone; Depressive Disorder; Disease Models, Animal; Fluoxetine; Inflammasomes; Interleukin-1beta; Male; Mice, Inbred ICR; Neuroimmunomodulation; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Prefrontal Cortex; Stress, Psychological; Terpenes; Uncertainty | 2015 |
Enzymatic Depletion of the Polysialic Acid Moiety Associated with the Neural Cell Adhesion Molecule Inhibits Antidepressant Efficacy.
Topics: Animals; Antidepressive Agents, Second-Generation; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Glycoside Hydrolases; Hippocampus; Male; Neural Cell Adhesion Molecule L1; Neuronal Plasticity; Rats; Rats, Sprague-Dawley; Sialic Acids; Testosterone; Treatment Outcome | 2016 |
The Role of Nitric Oxide in the Antidepressant Actions of 5-Aminoimidazole-4-Carboxamide-1-β-D-Ribofuranoside in Insulin-Resistant Mice.
Topics: Adenylate Kinase; Aminoimidazole Carboxamide; Animals; Antidepressive Agents; Combined Modality Therapy; Corticosterone; Depressive Disorder; Diet, High-Fat; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Activation; Fluoxetine; Imipramine; Insulin Resistance; Ketamine; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Physical Conditioning, Animal; Prefrontal Cortex; Ribonucleotides; Triazenes | 2016 |
Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Corticosterone; Creatine; Depression; Disease Models, Animal; Female; Fluoxetine; Ketamine; Mice; Models, Biological; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2016 |
Sulforaphane produces antidepressant- and anxiolytic-like effects in adult mice.
Topics: Adrenocorticotropic Hormone; Animals; Anti-Anxiety Agents; Anti-Inflammatory Agents; Antidepressive Agents; Anxiety Disorders; Chronic Disease; Corticosterone; Depressive Disorder; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Interleukin-6; Isothiocyanates; Male; Mice, Inbred ICR; Motor Activity; Random Allocation; Stress, Psychological; Sulfoxides; Tumor Necrosis Factor-alpha | 2016 |
Rhythmical Photic Stimulation at Alpha Frequencies Produces Antidepressant-Like Effects in a Mouse Model of Depression.
Topics: Animals; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Male; Mice; Mice, Inbred C57BL; Photic Stimulation; Selective Serotonin Reuptake Inhibitors | 2016 |
Anxiety- and Depression-Like States Lead to Pronounced Olfactory Deficits and Impaired Adult Neurogenesis in Mice.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Anxiety; Cell Proliferation; Corticosterone; Depression; Disease Models, Animal; Exploratory Behavior; Feeding Behavior; Fluoxetine; Grooming; Male; Mice; Mice, Inbred C57BL; Neurogenesis; Olfaction Disorders; Olfactory Mucosa; Olfactory Receptor Neurons; Reaction Time | 2016 |
Parity modifies the effects of fluoxetine and corticosterone on behavior, stress reactivity, and hippocampal neurogenesis.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Corticosterone; Dentate Gyrus; Depression, Postpartum; Disease Models, Animal; Doublecortin Protein; Estradiol; Estrous Cycle; Female; Fluoxetine; Maternal Behavior; Motor Activity; Neurogenesis; Neurons; Parity; Postpartum Period; Random Allocation; Rats, Sprague-Dawley; Stress, Psychological | 2016 |
Chronic 5-HT4 receptor agonist treatment restores learning and memory deficits in a neuroendocrine mouse model of anxiety/depression.
Topics: Aniline Compounds; Animals; Antidepressive Agents; Anxiety; Association Learning; Corticosterone; Depression; Fluoxetine; Learning; Male; Memory; Mice, Inbred C57BL; Piperidines; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT4 Receptor Agonists; Spatial Learning; Spatial Memory | 2016 |
Ovarian hormones, but not fluoxetine, impart resilience within a chronic unpredictable stress model in middle-aged female rats.
Topics: Age Factors; Animals; Antidepressive Agents; Corticosterone; Disease Models, Animal; Estradiol; Female; Fluoxetine; Ovariectomy; Ovary; Rats; Rats, Sprague-Dawley; Stress, Psychological | 2016 |
Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Corticosterone; Depression; Disease Models, Animal; Female; Fluoxetine; Imipramine; Muscarinic Antagonists; Random Allocation; Rats; Rats, Wistar; Receptors, Corticotropin-Releasing Hormone; Selective Serotonin Reuptake Inhibitors; Urinary Bladder; Urinary Bladder, Overactive | 2016 |
Fluoxetine normalizes the effects of prenatal maternal stress on depression- and anxiety-like behaviors in mouse dams and male offspring.
Topics: Animals; Animals, Newborn; Anxiety Disorders; Corticosterone; Depressive Disorder; Disease Models, Animal; Female; Fluoxetine; Male; Maternal Behavior; Mice; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Random Allocation; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2016 |
Prenatal SSRI alters the hormonal and behavioral responses to stress in female mice: Possible role for glucocorticoid resistance.
Topics: Animals; Anxiety; Behavior, Animal; Corticosterone; Female; Fluoxetine; Hypothalamo-Hypophyseal System; Metabolism, Inborn Errors; Mice; Motor Activity; Pituitary-Adrenal System; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Glucocorticoid; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2016 |
Antidepressant treatment differentially affects the phenotype of high and low stress reactive mice.
Topics: Adaptation, Psychological; Animals; Antidepressive Agents; Corticosterone; Depression; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Mice; Phenotype; Pituitary-Adrenal System; Species Specificity; Stress, Psychological; Treatment Outcome | 2016 |
Involvement of PI3K/Akt/FoxO3a and PKA/CREB Signaling Pathways in the Protective Effect of Fluoxetine Against Corticosterone-Induced Cytotoxicity in PC12 Cells.
Topics: Animals; Apoptosis; Brain-Derived Neurotrophic Factor; Corticosterone; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Fluoxetine; Forkhead Box Protein O3; Neurons; Neuroprotective Agents; PC12 Cells; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Tumor Suppressor Protein p53 | 2016 |
Evaluation of the antidepressant-like effect of musk in an animal model of depression: how it works.
Topics: Administration, Inhalation; Animals; Antidepressive Agents; Behavior; Brain-Derived Neurotrophic Factor; Corticosterone; Depression; Disease Models, Animal; Fatty Acids, Monounsaturated; Fluoxetine; Gene Expression; Hippocampus; Male; Mice; Receptors, Glucocorticoid; Stress, Psychological | 2017 |
Creatine Prevents Corticosterone-Induced Reduction in Hippocampal Proliferation and Differentiation: Possible Implication for Its Antidepressant Effect.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cell Differentiation; Cell Proliferation; Corticosterone; Creatine; Depression; Feeding Behavior; Female; Fluoxetine; Glial Fibrillary Acidic Protein; Hippocampus; Mice; Motor Activity; Neurons; Sucrose | 2017 |
Resveratrol Ameliorates the Depressive-Like Behaviors and Metabolic Abnormalities Induced by Chronic Corticosterone Injection.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Blood Glucose; Body Weight; Corticosterone; Depression; Disease Models, Animal; Drug Administration Schedule; Fluoxetine; Lipids; Male; Mice; Mice, Inbred ICR; Pioglitazone; Resveratrol; Stilbenes; Swimming; Thiazolidinediones | 2016 |
Anxiogenic-like effects of fluoxetine render adult male rats vulnerable to the effects of a novel stress.
Topics: Animals; Anxiety; Corticosterone; Corticotropin-Releasing Hormone; Energy Metabolism; Fluoxetine; Hypothalamo-Hypophyseal System; Hypothalamus; Male; Pituitary-Adrenal System; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Stress, Psychological | 2017 |
Antidepressant and anxiolytic-like behavioral effects of erucamide, a bioactive fatty acid amide, involving the hypothalamus-pituitary-adrenal axis in mice.
Topics: Adrenocorticotropic Hormone; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antioxidants; Corticosterone; Erucic Acids; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Maze Learning; Mice; Motor Activity; Pituitary-Adrenal System; Random Allocation; Stress, Psychological | 2017 |
Prenatal fluoxetine modifies the behavioral and hormonal responses to stress in male mice: role for glucocorticoid insensitivity.
Topics: Animals; Antidepressive Agents; Anxiety; Anxiety Disorders; Behavior, Animal; Corticosterone; Depressive Disorder, Major; Female; Fluoxetine; Glucocorticoids; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred ICR; Pituitary-Adrenal System; Pregnancy; Prenatal Exposure Delayed Effects; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2017 |
Sex-dependent effects of maternal corticosterone and SSRI treatment on hippocampal neurogenesis across development.
Topics: Animals; Corticosterone; Doublecortin Protein; Female; Fluoxetine; Hippocampus; Male; Neurogenesis; Neurons; Postpartum Period; Pregnancy; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sex Characteristics; Stress, Physiological | 2017 |
Preventive Effects of Ginseng Total Saponins on Chronic Corticosterone-Induced Impairment in Astrocyte Structural Plasticity and Hippocampal Atrophy.
Topics: Animals; Antidepressive Agents; Astrocytes; Atrophy; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Glial Fibrillary Acidic Protein; Hindlimb Suspension; Hippocampus; Male; Mice; Mice, Inbred C57BL; Panax; Saponins; Swimming | 2017 |
Silymarin ameliorates experimentally induced depressive like behavior in rats: Involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response.
Topics: Animals; Antidepressive Agents; Antioxidants; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Corticosterone; Cytokines; Depressive Disorder; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Fluoxetine; Hippocampus; Norepinephrine; Oxidative Stress; Rats, Wistar; Serotonin; Silymarin | 2017 |
Fluoxetine coupled with zinc in a chronic mild stress model of depression: Providing a reservoir for optimum zinc signaling and neuronal remodeling.
Topics: Animals; Antidepressive Agents, Second-Generation; Brain; Chronic Disease; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Male; Neurons; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Serotonin; Signal Transduction; Stress, Psychological; Sucrose; Weight Gain; Zinc | 2017 |
Antidepressant and pro-neurogenic effects of agmatine in a mouse model of stress induced by chronic exposure to corticosterone.
Topics: Agmatine; Anhedonia; Animals; Antidepressive Agents; Cell Proliferation; Corticosterone; Depressive Disorder; Disease Models, Animal; Female; Fluoxetine; Hippocampus; Mice; Motor Activity; Neurogenesis; Neuronal Plasticity; Random Allocation; Stress, Psychological | 2018 |
Perinatal fluoxetine increases hippocampal neurogenesis and reverses the lasting effects of pre-gestational stress on serum corticosterone, but not on maternal behavior, in the rat dam.
Topics: Animals; Behavior, Animal; Corticosterone; Female; Fluoxetine; Hippocampus; Maternal Behavior; Neurogenesis; Postpartum Period; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2018 |
Therapeutic potential of silymarin in chronic unpredictable mild stress induced depressive-like behavior in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cerebral Cortex; Corticosterone; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoxetine; Hippocampus; Male; Mice; Oxidative Stress; Silymarin; Stress, Psychological; Swimming | 2018 |
Hippocampal astrocyte atrophy in a mouse depression model induced by corticosterone is reversed by fluoxetine instead of benzodiazepine diazepam.
Topics: Animals; Antidepressive Agents; Astrocytes; Atrophy; Corticosterone; Depressive Disorder; Diazepam; Disease Models, Animal; Fluoxetine; Hippocampus; Male; Mice, Inbred C57BL; Random Allocation | 2018 |
The Role of Musk in Relieving the Neurodegenerative Changes Induced After Exposure to Chronic Stress.
Topics: Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Corticosterone; Disease Models, Animal; Fatty Acids, Monounsaturated; Fluoxetine; Hippocampus; Male; Mice; Receptors, Glucocorticoid; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2018 |
Antidepressant activity of vorinostat is associated with amelioration of oxidative stress and inflammation in a corticosterone-induced chronic stress model in mice.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Antioxidants; Anxiety; Chronic Disease; Corticosterone; Depressive Disorder; Disease Models, Animal; Fluoxetine; Hippocampus; Hydroxamic Acids; Inflammation; Male; Mice; Oxidative Stress; Random Allocation; Stress, Psychological; Vorinostat | 2018 |
Perinatal exposure to venlafaxine leads to lower anxiety and depression-like behavior in the adult rat offspring.
Topics: Adrenal Cortex Hormones; Aldosterone; Animals; Animals, Newborn; Anxiety; Anxiety Disorders; Behavior, Animal; Brain; Corticosterone; Depression; Depressive Disorder; Female; Fluoxetine; Hippocampus; Male; Maternal Behavior; Postpartum Period; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Venlafaxine Hydrochloride | 2018 |
Maternal exercise increases but concurrent maternal fluoxetine prevents the increase in hippocampal neurogenesis of adult offspring.
Topics: Animals; Anxiety; Corticosterone; Depression, Postpartum; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Female; Fluoxetine; Hippocampus; Hypothalamo-Hypophyseal System; Male; Maternal Behavior; Microtubule-Associated Proteins; Neurogenesis; Neuropeptides; Physical Conditioning, Animal; Pituitary-Adrenal System; Postpartum Period; Rats; Rats, Sprague-Dawley; Sex Factors; Stress, Psychological | 2018 |
Cholecalciferol counteracts depressive-like behavior and oxidative stress induced by repeated corticosterone treatment in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cholecalciferol; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Humans; Lipid Peroxidation; Male; Mice; Motor Activity; Oxidative Stress; Toxicity Tests, Acute; Toxicity Tests, Subchronic; Treatment Outcome; Vitamins | 2018 |
Single administration of agmatine reverses the depressive-like behavior induced by corticosterone in mice: Comparison with ketamine and fluoxetine.
Topics: Agmatine; Animals; Antidepressive Agents; Brain; Corticosterone; Depression; Disks Large Homolog 4 Protein; Excitatory Amino Acid Antagonists; Female; Fluoxetine; Ketamine; Mice; Receptors, AMPA | 2018 |
Antidepressant-like activities of live and heat-killed Lactobacillus paracasei PS23 in chronic corticosterone-treated mice and possible mechanisms.
Topics: Animals; Antidepressive Agents; Anxiety; Anxiety Disorders; Behavior, Animal; Brain; Corticosterone; Depression; Depressive Disorder; Disease Models, Animal; Fluoxetine; Hippocampus; Lacticaseibacillus paracasei; Male; Mice; Mice, Inbred C57BL; Prefrontal Cortex; Probiotics; Receptors, Glucocorticoid; Stress, Psychological | 2019 |
Lutein prevents corticosterone-induced depressive-like behavior in mice with the involvement of antioxidant and neuroprotective activities.
Topics: Animals; Antioxidants; Behavior, Animal; Corticosterone; Depression; Fluoxetine; Lutein; Male; Mice; Neuroprotective Agents; Selective Serotonin Reuptake Inhibitors | 2019 |
Maternal exposure to fluoxetine during gestation and lactation does not alter plasma concentrations of testosterone, oestrogen or corticosterone in peripubertal offspring.
Topics: Animals; Corticosterone; Estrogens; Female; Fluoxetine; Male; Maternal Exposure; Placenta; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sexual Maturation; Testosterone; Uterus | 2019 |
Two-hit model of postintensive care syndrome induced by lipopolysaccharide challenge and subsequent chronic unpredictable stress in mice.
Topics: Animals; Anxiety; Chronic Disease; Cognition Disorders; Corticosterone; Critical Care; Critical Illness; Disease Models, Animal; Fluoxetine; Hippocampus; Humans; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Selective Serotonin Reuptake Inhibitors; Stress, Physiological; Subacute Care; Syndrome | 2019 |
Methyl-CpG binding protein 2 functional alterations provide vulnerability to develop behavioral and molecular features of post-traumatic stress disorder in male mice.
Topics: Animals; Avoidance Learning; Conditioning, Psychological; Corticosterone; Epigenomics; Fluoxetine; Gene Expression; Male; Memory; Methyl-CpG-Binding Protein 2; Mice; Mice, Transgenic; Stress Disorders, Post-Traumatic | 2019 |
The effect of fluoxetine on astrocyte autophagy flux and injured mitochondria clearance in a mouse model of depression.
Topics: Animals; Antidepressive Agents; Astrocytes; Autophagosomes; Autophagy; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Hippocampus; Humans; Mice; Mitochondria; Primary Cell Culture | 2019 |
Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Adrenergic Neurons; Animals; Antidepressive Agents, Second-Generation; Brimonidine Tartrate; Cell Body; Corticosterone; Dendrites; Disease Models, Animal; Fluoxetine; Guanosine 5'-O-(3-Thiotriphosphate); Hypothalamo-Hypophyseal System; In Vitro Techniques; Isoquinolines; Locus Coeruleus; Male; Microdialysis; Naphthyridines; Norepinephrine; Pituitary-Adrenal System; Prefrontal Cortex; Presynaptic Terminals; Rats; Receptors, Adrenergic, alpha-2; Stress, Psychological; Sulfur Radioisotopes | 2019 |
Social instability is an effective chronic stress paradigm for both male and female mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Corticosterone; Disease Models, Animal; Estrous Cycle; Female; Fluoxetine; Hypothalamo-Hypophyseal System; Male; Mice; Pituitary-Adrenal System; Sex Characteristics; Social Behavior; Social Environment; Stress, Psychological | 2019 |
Fluoxetine attenuates stress-induced depressive-like behavior through modulation of hippocampal GAP43 and neurogenesis in male rats.
Topics: Animals; Behavior, Animal; Corticosterone; Depression; Fluoxetine; GAP-43 Protein; Hippocampus; Interleukin-6; Male; Neurogenesis; Neurons; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2020 |
Morus nigra leaves extract revokes the depressive-like behavior, oxidative stress, and hippocampal damage induced by corticosterone: a pivotal role of the phenolic syringic acid.
Topics: Animals; Antioxidants; Behavior, Animal; Cell Survival; Corticosterone; Depression; Fluoxetine; Gallic Acid; Hippocampus; Male; Mice; Morus; Neuroprotective Agents; Oxidative Stress; Plant Extracts; Plant Leaves | 2020 |
Protective Effects of Agmatine Against Corticosterone-Induced Impairment on Hippocampal mTOR Signaling and Cell Death.
Topics: Agmatine; Animals; Anti-Inflammatory Agents; Cell Death; Corticosterone; Dentate Gyrus; Fluoxetine; Hippocampus; Mice; Neurons; Neuroprotective Agents; Selective Serotonin Reuptake Inhibitors; TOR Serine-Threonine Kinases | 2020 |
Cholecalciferol abolishes depressive-like behavior and hippocampal glucocorticoid receptor impairment induced by chronic corticosterone administration in mice.
Topics: Animals; Antidepressive Agents, Second-Generation; Beclin-1; Behavior, Animal; Cholecalciferol; Corticosterone; Depression; Fluoxetine; Hippocampus; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Microtubule-Associated Proteins; Receptors, Glucocorticoid | 2020 |
Cognitive Improvement by Vorinostat through Modulation of Endoplasmic Reticulum Stress in a Corticosterone-Induced Chronic Stress Model in Mice.
Topics: Animals; Cognition; Corticosterone; Endoplasmic Reticulum Stress; Fluoxetine; Hippocampus; Mice; Vorinostat | 2020 |
Ursolic acid abrogates depressive-like behavior and hippocampal pro-apoptotic imbalance induced by chronic unpredictable stress.
Topics: Animals; Antidepressive Agents; Apoptosis; Behavior, Animal; Corticosterone; Depression; Fluoxetine; Hippocampus; Male; Mice; Motor Activity; Stress, Psychological; Triterpenes; Ursolic Acid | 2021 |
Corticosterone-induced Hippocampal 5-HT Responses were Muted in Depressive-like State.
Topics: Animals; Corticosterone; Fluoxetine; Hippocampus; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred C57BL; Pituitary-Adrenal System; Serotonin | 2021 |
Exercise and fluoxetine treatment during adolescence protect against early life stress-induced behavioral abnormalities in adult rats.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Corticosterone; Depression; Female; Fluoxetine; Hippocampus; Hypothalamo-Hypophyseal System; Male; Maternal Deprivation; Physical Conditioning, Animal; Pituitary-Adrenal System; Prefrontal Cortex; Rats; Rats, Wistar; Stress, Psychological | 2021 |
Ketamine, but not fluoxetine, rapidly rescues corticosterone-induced impairments on glucocorticoid receptor and dendritic branching in the hippocampus of mice.
Topics: Animals; Corticosterone; Depression; Fluoxetine; Hippocampus; Ketamine; Mice; Receptors, Glucocorticoid | 2021 |
5-HT
Topics: Animals; Anxiety; Corticosterone; Depression; Fluoxetine; Hippocampus; Mice; Serotonin | 2021 |
Postpartum corticosterone and fluoxetine shift the tryptophan-kynurenine pathway in dams.
Topics: Animals; Corticosterone; Depression, Postpartum; Depressive Disorder, Major; Female; Fluoxetine; Humans; Kynurenine; Postpartum Period; Pregnancy; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Tryptophan | 2021 |
Organic Cation Transporters are Involved in Fluoxetine Transport Across the Blood-Brain Barrier
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Blood-Brain Barrier; Chromatography, Liquid; Corticosterone; Endothelial Cells; Fluoxetine; Humans; Neoplasm Proteins; Prazosin; Rats; Tandem Mass Spectrometry | 2022 |
Galanin (1-15) Enhances the Behavioral Effects of Fluoxetine in the Olfactory Bulbectomy Rat, Suggesting a New Augmentation Strategy in Depression.
Topics: Animals; Antidepressive Agents; Corticosterone; Depression; Fluoxetine; Galanin; Humans; Peptide Fragments; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sucrose | 2022 |
Lower antidepressant response to fluoxetine is associated with anxiety-like behavior, hippocampal oxidative imbalance, and increase on peripheral IL-17 and IFN-γ levels.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Hippocampus; Humans; Hydrogen Peroxide; Interleukin-17; Mice; Oxidation-Reduction; Oxidative Stress | 2022 |
Evaluation of rosmarinic acid against myocardial infarction in maternally separated rats.
Topics: Animals; Body Weight; Brain-Derived Neurotrophic Factor; Cinnamates; Corticosterone; Depsides; Fluoxetine; Glutathione; Interleukin-10; Isoproterenol; Maternal Deprivation; Myocardial Infarction; Myocardium; Oxidative Stress; Rats; Rats, Wistar; Rosmarinic Acid; Superoxide Dismutase | 2022 |
Contribution of the Opioid System to the Antidepressant Effects of Fluoxetine.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Corticosterone; Fluoxetine; Mice; Mice, Knockout; Receptors, Opioid, delta; Selective Serotonin Reuptake Inhibitors | 2022 |
Paeoniflorin exhibits antidepressant activity in rats with postpartum depression via the TSPO and BDNF‑mTOR pathways.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Carrier Proteins; Corticosterone; Depression; Depression, Postpartum; Disease Models, Animal; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fluoxetine; Glucosides; Hippocampus; Humans; Monoterpenes; Pregnancy; Pregnanolone; Progesterone; Rats; Receptors, GABA-A; Stress, Psychological; Sucrose; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2022 |
Baicalin Ameliorates Corticosterone-Induced Depression by Promoting Neurodevelopment of Hippocampal via mTOR/GSK3β Pathway.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Fluoxetine; Glycogen Synthase Kinase 3 beta; Hippocampus; Male; Mammals; Mice; Reproducibility of Results; RNA, Messenger; TOR Serine-Threonine Kinases | 2023 |
Long-Term Effect of Moderate Hypoxia and Chronic Administration of Fluoxetine during the Neonatal Period on Cognitive and Stress-Hormonal Functions in Adult Male Rats.
Topics: Animals; Cognition; Corticosterone; Fluoxetine; Hypoxia; Male; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2023 |
Reproductive experience alters the effects of diazepam and fluoxetine on anxiety-like behaviour, fear extinction, and corticosterone levels in female rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Corticosterone; Diazepam; Estradiol; Extinction, Psychological; Fear; Female; Fluoxetine; Humans; Pregnancy; Pregnanolone; Progesterone; Rats | 2023 |
Organic cation transporter 2 contributes to SSRI antidepressant efficacy by controlling tryptophan availability in the brain.
Topics: Anhedonia; Animals; Antidepressive Agents; Brain; Corticosterone; Depressive Disorder, Major; Fluoxetine; Kynurenine; Mice; Organic Cation Transporter 2; Selective Serotonin Reuptake Inhibitors; Serotonin; Tryptophan | 2023 |
Geraniol attenuates behavioral and neurochemical impairments by inhibitions of HPA-axis and oxido-inflammatory perturbations in mice exposed to post-traumatic stress disorder.
Topics: Acetylcholinesterase; Animals; Corticosterone; Disease Models, Animal; Fluoxetine; Hippocampus; Hypothalamo-Hypophyseal System; Mice; Pituitary-Adrenal System; Stress Disorders, Post-Traumatic | 2023 |
A comparative analysis of depressive-like behavior: Exploring sex-related differences and insights.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Depression; Disease Models, Animal; Female; Fluoxetine; Hindlimb Suspension; Imipramine; Male; Mice; Swimming | 2023 |